Content about Pharmacy

March 24, 2014

AmerisourceBergen on Monday announced that it has reached a definitive agreement to acquire a minority stake in Profarma Distribuidora de Produtos Farmacêuticos S.A., a leading pharmaceutical wholesaler in Brazil.

VALLEY FORGE, Pa. — AmerisourceBergen on Monday announced that it has reached a definitive agreement to acquire a minority stake in Profarma Distribuidora de Produtos Farmacêuticos S.A., a leading pharmaceutical wholesaler in Brazil. In addition, AmerisourceBergen and Profarma will establish a joint venture for specialty distribution and services. 

March 24, 2014

A new analysis from Avalere Health released Monday found that consumers purchasing insurance through exchanges are twice as likely to face utilization management controls on prescription medications compared with people enrolled in employer-sponsored insurance plans.

WASHINGTON — A new analysis from Avalere Health released Monday found that consumers purchasing insurance through exchanges are twice as likely to face utilization management controls on prescription medications compared with people enrolled in employer-sponsored insurance plans. Utilization management controls, including prior authorization and step therapy, are administrative steps that patients and their physicians must complete to demonstrate appropriate use of the drugs.

March 24, 2014

Genentech announced that the Food and Drug Administration approved Xolair (omalizumab) for the treatment of chronic idiopathic urticaria, or CIU, which is a form of chronic hives.

SOUTH SAN FRANCISCO, Calif. — Genentech announced that the Food and Drug Administration approved Xolair (omalizumab) for the treatment of chronic idiopathic urticaria, or CIU, which is a form of chronic hives.

CIU is diagnosed when hives occur without cause, spontaneously present and reoccur for more than six weeks, the company said. The symptoms include swelling, severe itch, pain and discomfort that may last for months and, in some cases, years. 

March 24, 2014

IMS Health Holdings is expected to launch an initial public stock offering in two weeks, according to a report Sunday in the Wall Street Journal.

NEW YORK — IMS Health Holdings is expected to launch an initial public stock offering in two weeks, according to a report Sunday in the Wall Street Journal. The syndicated prescription data service could be valued as much as $7 billion, WSJ noted, citing people familiar with the matter, with a per-share price of as much as $21. 

March 24, 2014

As the March 31 enrollment deadline draws near, CVS/pharmacy and Ralphs grocery chain have inked deals with the Covered California exchange to promote the healthcare law inside their retail outlets, the Los Angeles Times has reported.

LOS ANGELES — As the March 31 enrollment deadline draws near, CVS/pharmacy and Ralphs grocery chain have inked deals with the Covered California exchange to promote the healthcare law inside their retail outlets, the Los Angeles Times has reported.

March 24, 2014

Celgene on Friday announced that the Food and Drug Administration has approved Otezla (apremilast), the company's oral, selective inhibitor of phosphodiesterase 4 (PDE4), for the treatment of adult patients with active psoriatic arthritis.

SUMMIT, N.J. — Celgene on Friday announced that the Food and Drug Administration has approved Otezla (apremilast), the company's oral, selective inhibitor of phosphodiesterase 4 (PDE4), for the treatment of adult patients with active psoriatic arthritis. A chronic disorder, psoriatic arthritis is characterized by pain, stiffness, swelling and tenderness of the joints, inflammation of specific ligaments and tendons, and a decrease in physical functioning. Otezla is the only FDA-approved oral treatment for psoriatic arthritis.

March 24, 2014

Upsher-Smith Laboratories on Monday announced that it has entered into a definitive agreement under which New Jersey-based Vertical Pharmaceuticals has acquired Upsher-Smith's rights to Divigel (estradiol gel) 0.1%, Nexa Plus Rx Prenatal Vitamin, and Provella, a probiotic dietary supplement.

MAPLE GROVE, Minn. — Upsher-Smith Laboratories on Monday announced that it has entered into a definitive agreement under which New Jersey-based Vertical Pharmaceuticals has acquired Upsher-Smith's rights to Divigel (estradiol gel) 0.1%, Nexa Plus Rx Prenatal Vitamin, and Provella, a probiotic dietary supplement. As part of the transaction, Upsher-Smith has transferred the new drug application for Divigel to Vertical Pharmaceuticals. 

March 21, 2014

Actavis earlier this week announced that it has entered into an agreement with Noven Pharmaceuticals to settle all outstanding patent litigation related to Actavis' generic version of Daytrana (methylphenidate transdermal system).

DUBLIN — Actavis earlier this week announced that it has entered into an agreement with Noven Pharmaceuticals to settle all outstanding patent litigation related to Actavis' generic version of Daytrana (methylphenidate transdermal system). Daytrana is a CNS stimulant indicated for the treatment of attention deficit hyperactivity disorder.

March 21, 2014

Advanced Care Scripts, a division of Omnicare Specialty Care Group, on Friday announced that it has been awarded specialty pharmacy accreditation from URAC, a Washington, D.C.-based healthcare accrediting organization.

ORLANDO, Fla. — Advanced Care Scripts, a division of Omnicare Specialty Care Group, on Friday announced that it has been awarded specialty pharmacy accreditation from URAC, a Washington, D.C.-based healthcare accrediting organization. URAC offers one of the only third-party, voluntary accreditation programs of this scope for the pharmacy benefit management and prescription services industries.  

March 21, 2014

Armada's Specialty Pharmacy Summit and Expo returns to the Wynn Las Vegas May 5 to 9, to celebrate a decade of leadership in the specialty pharmacy industry.

FLORHAM PARK, N.J. — Armada's Specialty Pharmacy Summit and Expo returns to the Wynn Las Vegas May 5 to 9 to celebrate a decade of leadership in the specialty pharmacy industry. To date, executives and key decision-makers from more than 700 companies have registered for this year's Summit, the company announced Friday.

March 21, 2014

Loblaw and Shoppers Drug Mart have announced that the Competition Bureau has approved Loblaw's acquisition of Shoppers Drug Mart, and the acquisition is expected to close March 28.

BRAMPTON AND TORONTO, Ontario — Loblaw and Shoppers Drug Mart have announced that the Competition Bureau has approved Loblaw's acquisition of Shoppers Drug Mart, and the acquisition is expected to close March 28.

March 21, 2014

Pharma Major Lupin announced that Lupin Pharmaceuticals, its U.S. subsidiary, has launched niacin extended-release tablets USP in 500-mg, 750-mg and 1,000-mg strengths.

MUMBAI and BALTIMORE — Pharma Major Lupin announced that Lupin Pharmaceuticals, its U.S. subsidiary, has launched niacin extended-release tablets USP in 500-mg, 750-mg and 1,000-mg strengths.

The drug is the generic version of AbbVie’s Niaspan tablets. It's used to reduce elevated TC, LDL-C, Apo B and TG levels, and to increase HDL-C in patients with primary hyperlipidemia and mixed dyslipidemia, the company said.

March 21, 2014

Danish pharmaceutical group Alk Abello, in association with Merck, expects to start selling its new dust mite allergy tablet in the United States in 2017, according to a Reuters report published Thursday.

NEW YORK — Danish pharmaceutical group Alk Abello, in association with Merck, expects to start selling its new dust mite allergy tablet in the United States in 2017, according to a Reuters report published Thursday

House dust mite-allergy is associated with allergic asthma and affects more than 30 million Americans.

March 21, 2014

New guidelines for using statins to treat high cholesterol and prevent cardiovascular disease are projected to result in 12.8 million more U.S. adults taking the drugs, according to a research team led by Duke Medicine scientists.

DURHAM, N.C. — New guidelines for using statins to treat high cholesterol and prevent cardiovascular disease are projected to result in 12.8 million more U.S. adults taking the drugs, according to a research team led by Duke Medicine scientists. Overall, of the 12.8 million additional U.S. adults recommended for statin use under the new guidelines, 10.4 million are people who would be prescribed the drugs for preventive care. Of those preventive users, 8.3 million would be people over the age of 60. 

March 21, 2014

Rx Response earlier this week established a new membership structure that will enable individual companies in the bio-pharmaceutical supply chain to become direct members.

WASHINGTON — Rx Response earlier this week established a new membership structure that will enable individual companies in the bio-pharmaceutical supply chain to become direct members.

March 21, 2014

Wegmans earlier this week introduced a medication synchronization pilot to its hub store in the Syracuse market called "My Meds Together," according to company executives.

ROCHESTER, N.Y. — Wegmans earlier this week introduced a medication synchronization pilot to its hub store in the Syracuse market called "My Meds Together," according to company executives. 

"It all ties into adherence, which is one of our priorities," Dan Ferrara, Wegmans VP pharmacy operations, told DSN

March 20, 2014

AstraZeneca on Wednesday launched Nexium Direct, a program that provides eligible patients the option of having brand-name Nexium delivered directly to their home.

WILMINGTON, Del. — AstraZeneca on Wednesday launched Nexium Direct, a program that provides eligible patients the option of having brand-name Nexium delivered directly to their home. Nexium Direct is part of AstraZeneca Direct, a web-based offering that delivers select brand name prescription medications from AstraZeneca. The medications are dispensed by a team of registered pharmacists and certified pharmacy technicians available through a collaboration with Eagle Pharmacy.

March 20, 2014

The Food and Drug Administration announced the approval of Impavido (miltefosine) to treat a tropical disease called leishmaniasis. Leishmaniasis is caused by Leishmania, a parasite transmitted to humans through sand fly bites.

SILVER SPRING, Md. — The Food and Drug Administration announced the approval of Impavido (miltefosine) to treat a tropical disease called leishmaniasis. Leishmaniasis is caused by Leishmania, a parasite transmitted to humans through sand fly bites. It's the first FDA-approved drug to treat cutaneous or mucosal leishmaniasis.

March 20, 2014

Johnson & Johnson on Wednesday named Ernesto Quinteros, recently of Belkin International, as its chief design officer.

NEW BRUNSWICK, N.J. — Johnson & Johnson on Wednesday named Ernesto Quinteros, recently of Belkin International, as its chief design officer. He will join the company May 5 and report to Sandi Peterson, group worldwide chairman. 

The chief design officer for Johnson & Johnson is a newly created role that expands the responsibility of the company’s Global Strategic Design Office beyond its consumer business origins to encompass the breadth of the company’s portfolio, including pharmaceuticals, medical devices, consumer and health and wellness.

March 20, 2014

Mallinckrodt, a specialty pharmaceuticals company, announced the completion of its acquisition of Cadence Pharmaceuticals for approximately $1.4 billion.

DUBLIN — Mallinckrodt, a specialty pharmaceuticals company, announced the completion of its acquisition of Cadence Pharmaceuticals for approximately $1.4 billion.

March 20, 2014

Two-thirds of Americans are satisfied with the way the healthcare system is working for them today, according to a Gallup poll released earlier this week.

PRINCETON, N.J. — Two-thirds of Americans are satisfied with the way the healthcare system is working for them today, according to a Gallup poll released earlier this week. While health insurance status was a major determinant of this satisfaction, even one-third of those who didn't have health insurance still reported they were satisfied.

March 20, 2014

Purdue Pharma recently announced that a Phase 3 study of an investigational extended‐release formulation of hydrocodone bitartrate met its primary efficacy endpoint by showing that patients with chronic low back pain treated with the once‐daily analgesic agent experienced statistically significant reduction in pain compared with placebo.

STAMFORD, Conn. — Purdue Pharma recently announced that a Phase 3 study of an investigational extended‐release formulation of hydrocodone bitartrate met its primary efficacy endpoint by showing that patients with chronic low back pain treated with the once‐daily analgesic agent experienced statistically significant reduction in pain compared with placebo. 

March 19, 2014

Ferring Pharmaceuticals announced that it received approval from the Food and Drug Administration for new labeling of its fertility products Menopur and Bravelle.

PARSIPPANY, N.J. — Ferring Pharmaceuticals announced that it received approval from the Food and Drug Administration for new labeling of its fertility products Menopur and Bravelle. The update is a result of the Combine trial, which showed that both Menopur and Bravelle can be safely mixed and administered in a single injection.

March 18, 2014

The American Pharmacists Association’s Academy of Student Pharmacists has named Phillip R. Oppenheimer, who has led University of the Pacific’s Thomas J. Long School of Pharmacy and Health Sciences for almost two decades, as the 2014 Outstanding Dean.

STOCKTON, Calif. — The American Pharmacists Association’s Academy of Student Pharmacists has named Phillip R. Oppenheimer, who has led University of the Pacific’s Thomas J. Long School of Pharmacy and Health Sciences for almost two decades, as the 2014 Outstanding Dean.

The award recognizes Oppenheimer for promoting the education of student pharmacists through community service, leadership and professional activities.

Oppenheimer will receive the award during the American Pharmacists Association annual meeting in Orlando on March 28.

March 18, 2014

Avella Specialty Pharmacy announced that it has registered with the Food and Drug Administration as an outsourcing facility for sterile compounding as outlined in the recently enacted Drug Quality and Security Act.

PHOENIX — Avella Specialty Pharmacy on Tuesday announced that it has registered with the Food and Drug Administration as an outsourcing facility for sterile compounding as outlined in the recently enacted Drug Quality and Security Act. Outsource facilities must consent to greater federal oversight including more frequent inspections and are required to demonstrate their adherence to specific “good manufacturing practices,” Avella noted.